Agrow is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Dow/Chromatin combine GMO technologies

Dow AgroSciences has reached an exclusive research and licensing agreement with the US biotechnology company, Chromatin (Chicago, Illinois), to combine Dow’s Exzact gene targeting with Chromatin’s mini-chromosome technology in the development of genetically modified maize, soybeans and canola. The deal creates a “technology synergy that delivers flexibility and efficiencies for modifying trait combinations on the mini-chromosome”, the companies point out. A second agreement grants Dow non-exclusive rights to the mini-chromosome technology. Chromatin has similar deals with Monsanto, Syngenta and Bayer CropScience ( Agrow No 575, p 3). Dow licensed the Exzact technology from Sangamo Biosciences last year ( Agrow No 546, p 3).



What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts